{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T15:57:42Z","timestamp":1777823862164,"version":"3.51.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.cld.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T19:08:08Z","timestamp":1540580888000},"page":"81-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Acute Alcoholic Hepatitis"],"prefix":"10.1016","volume":"23","author":[{"given":"Gene Y.","family":"Im","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.cld.2018.09.005_bib1","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib2","first-page":"408","article-title":"Liver related mortality in the US is underestimated","volume":"52","author":"Asrani","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.510250120","article-title":"Excess weight risk factor for alcoholic liver disease","volume":"25","author":"Naveau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2018.09.005_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2302\/kjm.48.184","article-title":"Pathogenesis of alcoholic liver disease: newer mechanisms of injury","volume":"48","author":"Crabb","year":"1999","journal-title":"Keio J Med"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.23596","article-title":"Assessing the drinking status of liver transplant patients with alcoholic liver disease","volume":"19","author":"Allen","year":"2013","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/add.12609","article-title":"Who under-reports their alcohol consumption in telephone surveys and by how much? An application of the 'yesterday method' in a national Canadian substance use survey","volume":"109","author":"Stockwell","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.cld.2018.09.005_bib8","unstructured":"Hope A. Dublin: health service executive; 2009. A standard drink in Ireland: what strength? Available at: www.lenus.ie\/hse\/handle\/10147\/80600. Accessed October 4, 2018."},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a009909","article-title":"Alcohol intake assessment: the sober facts","volume":"150","author":"Feunekes","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cld.2018.09.005_bib10","unstructured":"What\u2019s a \u201cstandard\u201d drink? Rethinking drinking. Available at: http:\/\/rethinkingdrinking.niaaa.nih.gov\/whatcountsdrink\/whatsastandarddrink.asp. Accessed October 4, 2018."},{"key":"10.1016\/j.cld.2018.09.005_bib11","unstructured":"Available at: https:\/\/www.centeronaddiction.org\/addiction-research\/reports\/national-survey-primary-care-physicians-patients-substance-abuse. Accessed October 4, 2018."},{"issue":"10","key":"10.1016\/j.cld.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology"},{"issue":"suppl 1","key":"10.1016\/j.cld.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"A233","DOI":"10.1136\/gut.2011.239301.492","article-title":"Is histology required for the diagnosis of alcoholic hepatitis? A review of published randomised controlled trials","volume":"60","author":"Hamid","year":"2011","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1572-0241.2006.01034.x","article-title":"Spectrum of liver histology in presumed decompensated alcoholic liver disease","volume":"102","author":"Elphick","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.005_bib16","first-page":"A231","article-title":"Interet de la biopsie hepatique pour la selection des sujets suspects d\u2019hepatite alcoolique aigue. Journees francophones d\u2019hepatologie et de patholigies digestives","volume":"16","author":"Mathurin","year":"1992","journal-title":"Gastroenterol Clin Biol"},{"issue":"8","key":"10.1016\/j.cld.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A\u00a0randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.cld.2018.09.005_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2011.02.021","article-title":"The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis","volume":"55","author":"Mookerjee","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"44","key":"10.1016\/j.cld.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.3748\/wjg.v19.i44.7825","article-title":"Is liver biopsy necessary in the management of alcoholic hepatitis?","volume":"19","author":"Dhanda","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/00365528309181659","article-title":"The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis","volume":"18","author":"Kryger","year":"1983","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A\u00a0histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2008-1041748","article-title":"Pathology of alcoholic liver diseases","volume":"1","author":"Popper","year":"1981","journal-title":"Semin Liver Dis"},{"issue":"10","key":"10.1016\/j.cld.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep4.1119","article-title":"Prediction of histologic alcoholic hepatitis based on clinical presentation limits the need for liver biopsy","volume":"1","author":"Roth","year":"2017","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.cld.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.cgh.2014.02.027","article-title":"Acute-on-chronic liver failure: a new clinical entity","volume":"13","author":"Moreau","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gut.2009.189639","article-title":"Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study","volume":"59","author":"Katoonizadeh","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1530-0277.2010.01374.x","article-title":"Effect of detoxification on liver stiffness assessed by Fibroscan\u00ae in alcoholic patients","volume":"35","author":"Gelsi","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2015.09.040","article-title":"Transient and 2-dimensional shear-wave elastography provide comparable assessment of alcoholic liver fibrosis and cirrhosis","volume":"150","author":"Thiele","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.29080","article-title":"A\u00a0prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis","volume":"66","author":"Bissonnette","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2018.09.005_bib31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12654","article-title":"Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort","volume":"39","author":"Papastergiou","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/apt.12414","article-title":"The management of alcoholic hepatitis: a prospective comparison of scoring systems","volume":"38","author":"Lafferty","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.21680","article-title":"A\u00a0modified international normalized ratio as an effective way of prothrombin time standardization in hepatology","volume":"46","author":"Bellest","year":"2007","journal-title":"Hepatology"},{"issue":"5 suppl 1","key":"10.1016\/j.cld.2018.09.005_bib35","first-page":"S-806","article-title":"Does selection of prothrombin time normal value alter prognosis according to Maddrey discriminant function in alcoholic hepatitis?","volume":"138","author":"Battish","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib36","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib37","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A\u00a0day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.09.005_bib42","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis","volume":"42","author":"Srikureja","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib43","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"NACSELD. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American Consortium for the Study of End-Stage Liver Disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2018.09.005_bib44","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cld.2018.09.005_bib45","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1136\/gut.2006.099226","article-title":"The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids","volume":"56","author":"Forrest","year":"2007","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cld.2018.09.005_bib46","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A\u00a0new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib48","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib49","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1053\/j.gastro.2017.10.048","article-title":"Combination of gene expression signature and model for end-stage liver disease score predicts survival of patients with severe alcoholic hepatitis","volume":"154","author":"Tr\u00e9po","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2018.09.005_bib51","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib52","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep4.1176","article-title":"Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome","volume":"2","author":"Maras","year":"2018","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.cld.2018.09.005_bib53","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2017.11.022","article-title":"Molecular ellipticity of circulating albumin-bilirubin complex associates with mortality in patients with severe alcoholic hepatitis","volume":"16","author":"Das","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2018.09.005_bib54","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib55","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","article-title":"Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival","volume":"66","author":"Altamirano","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.09.005_bib56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.005_bib57","unstructured":"Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01912404. Accessed October 4, 2018."},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2018.05.012","article-title":"Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis","volume":"69","author":"Peeraphatdit","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2018.09.005_bib59","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1572-0241.2008.01837.x","article-title":"Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function","volume":"103","author":"Lucey","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.005_bib60","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","article-title":"Alcohol-related cirrhosis\u2013early abstinence is a key factor in prognosis, even in the most severe cases","volume":"104","author":"Verrill","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.cld.2018.09.005_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcoholic hepatitis","volume":"38","author":"Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2018.09.005_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","author":"Dumortier","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib63","first-page":"13","article-title":"To hold (enteral feeding) or not to hold: that is the question; a commentary and tutorial","volume":"36","author":"Chan","year":"2012","journal-title":"Pract Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib64","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1016\/j.eclnm.2011.10.001","article-title":"Short term nasogastric versus oral feeding in hospitalised patients with advanced cirrhosis: A randomised trial","volume":"2011","author":"Tai","year":"2011","journal-title":"e-SPEN"},{"issue":"7\u20138","key":"10.1016\/j.cld.2018.09.005_bib65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0899-9007(00)00249-5","article-title":"Enteral versus parenteral nutrition: the significance of bacterial translocation and gut-barrier function","volume":"16","author":"MacFie","year":"2000","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib66","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(90)90293-A","article-title":"Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial","volume":"98","author":"Cabre","year":"1990","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib67","first-page":"269A","article-title":"Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial","volume":"60","author":"Moreno","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cld.2018.09.005_bib69","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2014a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2018.09.005_bib70","first-page":"170A","article-title":"Corticosteroids improve 28-day survival in patients with severe alcoholic hepatitis: individual data analysis of the last 5 randomized controlled trials","volume":"48","author":"Mathurin","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib71","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28\u00a0days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.cld.2018.09.005_bib72","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"STOPAH trial. Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis","volume":"60","author":"Gustot","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2018.09.005_bib74","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s00535-017-1336-z","article-title":"Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study","volume":"52","author":"Parker","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2018.09.005_bib75","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0168-8278(12)60005-1","article-title":"Management of alcoholic hepatitis","volume":"56","author":"Mathurin","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib76","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jhep.2014.11.003","article-title":"Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding","volume":"62","author":"Rudler","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib77","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","article-title":"Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two veterans administration cooperative studies","volume":"19","author":"Mendenhall","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"issue":"19","key":"10.1016\/j.cld.2018.09.005_bib78","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2018.09.005_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A\u00a0randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.hepres.2005.12.005","article-title":"A\u00a0dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice","volume":"34","author":"Wang","year":"2006","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.cld.2018.09.005_bib81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2018.09.005_bib82","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.dld.2007.08.006","article-title":"Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure","volume":"39","author":"Di Campli","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib83","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cld.2018.09.005_bib84","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3748\/wjg.v19.i7.1104","article-title":"Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"19","author":"Duan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2018.09.005_bib85","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib86","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/157488806778226759","article-title":"Therapeutic potential of bone marrow stem cells for liver diseases","volume":"1","author":"Popp","year":"2006","journal-title":"Curr Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib87","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.cld.2018.09.005_bib88","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.3748\/wjg.v21.i16.4975","article-title":"Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis","volume":"21","author":"Higuera-de la Tijera","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2018.09.005_bib90","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib91","article-title":"Pentoxifylline for alcoholic hepatitis","author":"Whitfield","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib93","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.005_bib94","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"issue":"16","key":"10.1016\/j.cld.2018.09.005_bib95","article-title":"Antioxidant supplements for liver diseases","author":"Bjelakovic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2018.09.005_bib96","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2013a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2018.09.005_bib97","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:27Z","timestamp":1761069387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118300813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1089326118300813"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.09.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Alcoholic Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}